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- µL: microlitres. 
- 2D: two dimensional. 
- 3D: three dimensional. 
- 3-MC: 3-methylcholanthrene. 
- 3R: Reduce, Replace and Refine.  
- AR: aspect ratio.  
- CTA: cell transformation assay. 
- DMSO: dimethyl sulfoxide 
- ECM: extracelullar matrix. 
- EtOH: ethanol 
- HCC: hepatocellular carcinoma.  
- mL: millilitres. 
- NC: negative control 
- OECD: Economic Co-operation and Development.  
- PAHS: polycyclic aromatic hydrocarbons.  
- PBS: Buffered Saline solution.  
- PHH: human primary human hepatocytes.  
- SC: solvent control.  
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Monolayer in vitro cultures of hepatic cells, so-called two-dimensional (2D) liver models do not 
adequately mimic the natural cell microenvironment because of the lack of different biological 
features and functions such as cell-to-cell and cell-to-matrix interactions. That is why there is 
a need to develop and improve three-dimensional (3D) hepatic cell (liver) models, 
characterized by higher expression of liver cell markers and cell interactions, although they still 
present some limitations and special requirements.  
 
This study aims to optimize and adapt 3D HepG2 cell-based transformation assay applicable 
for biomedicine, carcinogenicity research and toxicology. Within the proposed protocol, HepG2 
cells spheroids were first exposed to an initiator (3-methylcholanthrene, 3-MC) followed by the 
exposure to promotor (12-O-tetradecanoylphorbol-13- acetate, TPA) to create a tumor 
environment and characterize a new hepatocellular carcinoma in vitro model. The spheroids 
were monitored within a culture with a non-destructive and non-invasive bright field 
microscopy-based assay. The analysis is suitable with manual high-speed automated 
microscopic image acquisition and automated analysis using an in-house built macro 
'Spheroid_Finder' in Fiji/ImageJ software. This protocol was essential to characterize and 
quantify 3D spheroid formation, size and shape.  
 
The results show that spheroids treated with solvent controls did not differ from non-treated 
spheroids in size or shape. Interestingly, the spheroids treated with 3-MC alone and with the 
combination with TPA were smaller than the control spheroids, and their shape and 
compactness were also affected. On the other hand, spheroids treated with TPA alone were 
mildly bigger than the control ones, and their shape and compactness were changed. It should 
be emphasized that to confirm cell transformation, the gene expression related to neoplastic 
and hepatocellular carcinoma-derived cell lines phenotypes will be further evaluated with RT-
qPCR, as well as spheroids functionality by measuring albumin, urea or lactate in the collected 
medium. Despite this assay needing further optimization and validation to confirm its potential, 
we conclude that CTA assay utilizing HepG2 3D spheroids can be a promising tool for 
screening carcinogenicity potential of chemicals or new anti-cancer in biomedical, 






Cancer has become a significant public health concern, being worldwide the second leading 
cause of morbidity and mortality after cardiovascular diseases. Cancer's incidence and 
prevalence rates are high, and they keep increasing, being responsible in 2020 for 19 million 
new cases and 9 million deaths (1).  
 
While cancers can not be completely avoided, evidence strongly suggests that susceptibility 
to the disease can be curbed significantly by reducing the impact of several risk factors. 
Different interrelated causes can contribute to high cancer incidence as biological agents such 
as viral and bacterial infections, exposure to synthetic chemicals through work or consumer 
products, and lifestyle factors such as exposure to sunlight, poor diet, being overweight, and 
tobacco and/or alcohol consumption. On the other hand, we need to be conscious of family 
history and ageing, representing unavoidable risk factors (2). These risk factors are reported 
to collectively contribute to the development of 70–95% of all cancers (3,4).  
 
Chemicals are part of our daily life. When properly used, chemicals significantly contribute to 
improving our quality of life, health and well-being. Otherwise, some chemicals are highly 
hazardous and can negatively affect our health and environment when they are improperly 
managed (4,5,6). The cancer incidence attributable to exposure to toxic chemicals has been 
estimated to be between 1% and 19% (3). There are many variables to consider in chemically 
induced carcinogenesis, including duration of exposure, demography, geography, 
environment, and individual susceptibility (3).  
 
The exogenous chemicals that cause cancer are known as a carcinogen, and they are 
responsible for carcinogenesis, a process that occurs when normal cells are transformed into 
cancer cells (7). Chemical carcinogens can be classified into three main groups (8,9): 
 
- Ultimate carcinogens are chemicals with a direct action whose structure confers them 
the capacity to induce cancer without a previous metabolic activation in the host 
organism.  
 
- Procarcinogens, are chemicals that only become active after a previous metabolic 




- Co-carcinogens, are chemical substances that can not induce cancer when 
administered alone but can enhance the carcinogenic effect of other substances.  
Carcinogenesis is recognized as a multipath process in which distinct molecular and cellular 
alterations occur, consisting of separate but closely linked stages of initiation, promotion, 
and progression (Figure 1) (5,10,11): 
 
- The initiation process involves the appearance of mutation or alteration of genes, that 
might arise spontaneously or induced by exposure to a carcinogenic agent. This initiation 
can lead to dysregulation of biochemical and cellular signalling pathways associated with 
cell proliferation, survival, and differentiation. It can be influenced by several factors, such 
as the rate and type of carcinogenic metabolism and the response of the DNA repair 
function.  
 
- The promotion stage is a process in which actively proliferating preneoplastic cells 
accumulate. It is a relatively lengthy and reversible process. 
 
-  Progression is the final stage of neoplastic transformation, between a premalignant lesion 
and the development of invasive cancer. In this phase, genetic and phenotypic changes, 
as well as cell proliferation, finally occur. Progression involves a rapid increase in the tumor 
size, where the cells may undergo further mutations with invasive and metastatic potential. 
 
Figure 1. A brief description of initiation, promotion, and progression in the carcinogenesis 
process. Adapted from Basu A,  2018 (12). 
 
 
Depending on the chemical structure and mechanisms, carcinogens can be classified as 
initiating (genotoxic) agents or promoting (non-genotoxic) agents, with several 
fundamental differences (12): 
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- After repeated exposure to initiating agent in a small dosage or a single large exposure 
leads to carcinogenesis, in contrast to promoting agents, which are not carcinogenic 
alone. 
 
- An initiating carcinogen is irreversible and additive, whereas the effect of a promoting 
agent is reversible at the early stages. 
 
- An initiating agent is mutagenic and binds to cellular macromolecules such as DNA, 
while there is no evidence of covalent binding by a promoting agent (promoting agents 























Figure 2. Chemical structures of typical initiating and promoting agents. Adapted from Basu 
A,  2018 (12).  
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Initiating agents are structurally different chemicals, including polycyclic aromatic 
hydrocarbons (PAHs) such as benzo[a]pyrene or 7,12-dimethyl-benz[a]anthracene agents, 
nitroaromatic compounds, tobacco-specific nitrosamines, fuchsine (a magenta dye), aromatic 
amines usually formed during the cooking of meat, a naturally occurring molecule produced by 
Aspergillus flavus find in contaminated food (aflatoxin B1) and industrial chemicals (e.g., vinyl 
chloride; Figure 2). The promoting agents include for example 12-O-tetradecanoylphorbol-
13-acetate, benzoyl peroxide, and chrysarobin (12) (Figure 2).  
 
Traditionally, carcinogenicity bioassays evaluating the carcinogenic potential of chemicals 
require animals. However, animal studies have ethical, practical, and economic limitations, due 
to their high cost, long time for it to be performed and many animals required (13). Nowadays, 
for toxicology studies, the European Union has promoted the development of different 
methods, as an alternative to in vivo models to succeed implementing the 3R principles 
(Reduce, Refine, and Replace) (14). The 3R principles and the revolution in 21st toxicology 
(15) demands an urgent need for advanced development of efficient in vitro models for the 
safety assessment, including two-dimensional (2D) and three-dimensional (3D) in vitro cell 
models (Figure 3). 
 
2D cell culture models or monolayer in vitro cultures of mammalian adherent cells are 
characterized by the growth of the cells in a simple, flat monolayer, which is attached to the 
stiff, typically plastic, surface (16). They have been traditionally used for studying the adverse 
effects of chemicals and consumer products, including assessing the carcinogenic potential of 
chemicals using cell transformation assays (CTAs).  The 2D CTAs use different cell types such 
as the Syrian Hamster embryo cells (SHE), liver progenitor WB F344 cells, embryonic mouse 
fibroblasts BALB/c 3T or Bhas 42 cells, which were established by transfection of BALB/c 3T3 
cells with v-Ha-ras (14,17,18,19). The principle of CTAs is to evaluate the effects of chemicals 
on the growth of specific cell types and their potential progression through a transformation 
process from being normal cells to fully malignant cells. Experimental protocols include the 
exposure of 2D monolayer to an initiator (e.g., benzo[a]pyrene or 3-MC) followed by the 
exposure to a promotor (e.g., TPA), and an easily detectable endpoint is counting malignant 
foci of transformed cells. However, the validation performance of CTAs was not considered to 
be sufficiently robust for regulatory test guideline purposes at the Organisation for Economic 




In general, 2D cell culture models are prone to give misleading results because they do not 
adequately mimic the natural cell microenvironment. The main drawback of 2D models is the 
lack of biological functions due to limited cell-to-cell and cell-to-extracellular matrix (ECM) 
interactions (20).  Referring to 2D hepatic models, these result in decreased cell 
differentiation, modified cell signalling pathways, and a reduced expression and activity of 
several hepatic enzymes, as CYP450, implicated in the metabolism of xenobiotic substances 
(phase I and II enzymes) (21). The liver is the primary organ responsible for drug metabolism. 
In particular, the effects of chemicals and drugs depends on their liver bioactivation and 
hepatocellular uptake can be misrepresented, as activities of biotransformation enzymes and 
membrane transporters decrease in monolayer cultures, along with other hepatocyte-specific 
functions (16,22). These limitations lead to the development of new alternatives to 2D hepatic 
cell culture.  
 
In contrast, newly developed 3D cell culture models (Figure 3) provide an attractive 
alternative better reflecting in vivo physiology or pathophysiology (23,24). Specifically, 3D 
hepatic (liver) cell culture models present better cell-cell and cell-ECM interactions and a higher 
level of liver-specific functions, including metabolic enzyme activities as well as cell 
morphology and biochemical properties, which reflect in vivo conditions more accurately (20). 
In addition, it was found that 3D liver culture systems: 
 
- Counteract de-differentiation and progressive loss of hepatocellular characteristics of 
primary hepatocytes in vitro. 
 
- Improve liver-specific functions of permanent hepatocellular carcinoma (HCC) derived cell 
lines (such as HepG2). 
 
- Stimulate hepatic differentiation of human pluripotent stem cells, adult stem cells or 
progenitor cells (16).  
 
 
Many 3D cell culture models exist, often categorized as scaffold-based models, scaffold-
free models, or specialized 3D culture platforms as microfluidic devices (e.g., organ-on-
chips) or micropatterned plates with ECM components (Figure 3). Each type has its 
advantages and disadvantages (25), and it is important to choose the most appropriate 3D cell 




Figure 3. Classification of in vitro tissue models and their examples. Adapted from Langhans 
SA, 2018 (26).  
 
 
Because a scaffold-free 3D liver spheroid model was used in the practical part of the project, 
this type of 3D model will be described more deeply. Multicellular spheroids are a type of 
scaffold-free 3D models. They are large cell spheres, formed by the spontaneous tendency of 
cells to aggregate, without using an exogenous scaffold or matrix to support the cells (27). The 
multicellular spheroid formation involves three critical steps (28). First, dispersed cells 
initially are drawn closer to form loose aggregates. Then, direct cell-cell contact starts to be 
more and more intensive. Finally (after several days), cells are compacted into solid 
aggregates and form compact multicellular spheroids. The initial cell suspension seeded is 
going to determine the size of spheroids. The big advantage of multicellular spheroids is their 
simple spherical geometry allowing easier modelling of dynamic processes, such as drugs 
diffusion and cell invasion and angiogenesis due to its characteristics as well-established small 





Multicellular spheroids mimic physiological characteristics of tissues or tumors regarding cell-
cell contact, and ECM-cell contacts, due to their intensive cell-cell interaction and their capacity 
to synthesize their own ECM, allowing natural cell-matrix interactions (26). Specifically, 
scaffold-free 3D liver spheroid cultures can be formed from different liver cell sources such 
as primary human hepatocytes (PHHs), immortalized normal liver cell lines or HCC-derived 
cell lines (such as HepG2 or HepaRG). Furthermore, growing immortalized or cancer-derived 
cell lines in liver spheroids promote a more mature hepatic phenotype than the same cells 
cultured as 2D monolayers, based on hepatocyte functionality and the expression of drug 
metabolism enzymes and transporters (30). 
 
Multicellular spheroids can be prepared using different approaches such as hanging drop, low 
attachment plate or magnetic levitation (Figure 3). Additionally, micromolds castings, which 
will be utilized for preparing agarose gels followed by spheroid formation. Micromolds for the 
directed self-assembly of microtissues are flexible, transparent, and could be autoclaved and 
re-used (31). Different types of micromolds exist, characterised by different sizes, and 
designed to fit 6-well, up to 96-well tissue culture plates (some examples in Figure 4A), sharing 
some common features (31). 
 
- A cell-seeding chamber is a large rectangular recess that collects a single cell suspension 
and lets cells settle down under gravitational force into the smaller cell aggregation 
recesses (Figure 4B). 
 
- Cell aggregation recesses locate on the bottom of the agarose gel and extend downward 
from the floor of the seeding chamber increasing cell-to-cell contact as cells are collected 
on the concave bottoms of recesses (Figure 4C; 4D).  
 
- Medium exchange ports help to place a pipet between the gel and the tissue culture plate 





Figure 4. Micromolded nonadhesive gels guide cellular self-assembly. (A) Micromolds (top 
line) used to cast micromolded agarose gels (bottom line) designed to fit different tissue culture 
plates. (B) The self-assembly protocol. Firstly, agarose gels are cast and equilibrated in culture 
medium (i). Secondly, a cell suspension is added to the seeding chamber, (ii) the cells settle 
down into the recesses thanks to gravitational force (iii) and interact at the bottom of the 
concave recesses and self-assemble to form the spheroids (iv). (C) Photomicrographs cell 
suspension (top images) and formed spheroids 24 hours later (bottom images). (D) Side-on 
view of self-assembly of cells in the micromolds. Cells settle into the recesses immediately 
after seeding (top panels) and form spheroidal microtissues within one day (bottom panels). 
Scale bars, 200 µm. Adapted from Napolitano AP et al. 2007  (31).  
 
When 3D spheroids are designed, an indispensable requirement is cell type selection. 
Because in the practical part, a liver in vitro cell model was used, we will focus on liver (hepatic) 
spheroids. The liver comprises hepatocytes, being 70-80% of the cytoplasmic liver mass (32).  
PHHs are widely recognised as the best standard for studying metabolism and liver functions 
for two main reasons: human origin and expression of relevant human metabolic enzymes 
(33). On the other hand, their availability is limited, interindividual variation is high, the process 
of isolation is complex and the behaviour of these hepatocytes in cell culture differs from 
human body hepatocytes in situ, because the lifetime is short, dedifferentiation and loss of 
hepatocyte functions and phenotypes occur in 2D models rapidly. That is the reason why PHHs 
are not suitable for routine screening of toxic compounds. Hepatic carcinoma-derived cell 
lines (such as HepG2 cells), and stem cell-based cultures, including induced pluripotent 
stem cells (iPSCs), adult stem cells or embryonic stem cells, are suitable alternatives. These 
types of cell cultures have almost unlimited growth availability, higher reproducibility of results, 
and their availability is much higher than in the case of PHHs. Furthermore, these cell lines 
sustain several phenotypic and functional characteristics of liver cells, mainly in 3D models. 
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Therefore, they give facilities on cell culturing, and the maintenance of key enzymes involved 
in metabolism (21).  
 
Currently, progress in automatic image acquisition, analysis, and processing of large amounts 
of data speed up using of multicellular spheroids as an  in vitro liver model in drug discovery 
and toxicology (27). Therefore, a model of multicellular spheroids formed by liver cells was 
used to study the carcinogenicity potential of chemicals. The objective of this project was to 
characterize 3D HepG2 cell CTA assay to establish a new in vitro model that adequately 
mimics in vivo model characteristics and will be useful in drug discovery and cancer 
research, including a potential carcinogenic screening. 
 
The specific aims of the study were:  
 
- To adapt the protocol of a traditional 2D in vitro cell transformation assay (CTA) to a 3D 
CTA assay using scaffold-free spheroids formed by human liver carcinoma HepG2 cells.  
 
- To optimize culture conditions for 3D CTA assay using: 
 
• 3-methylcholanthrene (3-MC), a PAH and potent aryl hydrocarbon receptor 
agonist that is formed as a byproduct of the incomplete combustion of various 
organic substances like coal, garbage, gas and oil (17,34).   
 
• TPA (phorbol ester 12-O-tetradecanoylphorbol-13- acetate), a hazardous tumor 
promoter, and an active component of croton oil. TPA is a potent activator of protein 
kinases C (PKC) and inductor PKC  of signalling pathways involved in gene 
transcription, cell growth, differentiation, programmed cell death, immune pathway, 













The HepG2 cells (American Type Culture Collection ATCC®; HB-8065) were cultured in MEM 
medium (Cat. No. 61100-103; ThermoFisher, Waltham, Massachusetts, USA), containing 
Earle’s salts, L-glutamine and phenol red and further supplemented with 1.5 g/L NaHCO3 (Cat. 
No. 30067-AP0-G1000-1; LACH-NER, Neratovice, Czech Republic), 1× Non-Essential Amino 
Acids (Cat. No. M7145; Sigma-Aldrich, Prague, Czech Republic), 1 mM sodium pyruvate (Cat. 
No. S8636; Sigma-Aldrich) and 10% fetal bovine serum (Cat. No. FB-1001/100; Biosera, 
Nuaille, France). For the long incubation, the antibiotic normocin (final concentration: 100 
mg/mL; Cat. No. ant-nr-1; Invivogen, Huissen, The Netherlands) was added. HepG2 cell line 
was maintained at 37 °C in a cell incubator at 95% relative humidity and 5% of CO2.  
 
Cells were routinely cultured in the culture medium and Tissue Culture Flask T25 (Cat. No. 
92424; TPP, Trasadingen, Switzerland). Cells were sterilely handled (passaging or seeding 
cells) inside the biosafety cabinet. During the cell passaging, the culture medium was removed 
from the flask and the cells were washed twice with 2.0-3.0 millilitres (mL) of Phosphate 
Buffered Saline solution (PBS), containing NaCl 137mM (Cat. No. S3014; Sigma-Aldrich), KCl 
2.7 mM (Cat. No. P9541; Sigma-Aldrich), Na2HPO4 8.1 mM (Cat. No. S5136; Sigma-Aldrich), 
KH2PO4 1.5mM (Cat. No. P5655; Sigma-Aldrich) and deionized water (pH between 7.2-7.4). 
Then, 500 microlitres (µL) of 1× trypsin-EDTA (Cat. No. XC-T1717; Biosera) were added to 
the flask and incubated in the incubator for 2-4 minutes (min) to let cells detach from the 
surface. After checking that cells are adequately detached, 1.5-2.0 mL of MEM medium were 
added to inhibit the trypsin activity.  
 
Then, the cell clusters (clumps) were resuspended and removed the remaining attached cells 
by gently pipetting the cell solution several times up and down. Finally, an optic microscope 
(TCM 400; Labomed, Capelle aan den Ijssel, the Netherlands) was used to check if HepG2 
cells were properly separated. If necessary, a needle was used to separate cells properly to 
get a single-cell solution. At this point, a part of the cell suspension was transferred to a new 
flask; 20 µL of cell suspension were pipetted in a slide to calculate cell concentration using an 
automated cell counter (Nexcelom Bioscience, Lawrence, MA, USA), and finally the rest of the 
cell suspension was used for cell seeding to form 3D spheroids.  
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Three-Dimensional Cell Culture  
 
• 3D Petri Dish® Casting 
 
The 3D HepG2 cell spheroids were created using 3D Petri Dish® cast with 35 recesses. In 
brief, the molten agarose was first prepared, specifically 2% agarose (w/v; Cat. No. A9539-
10G; Sigma-Aldrich) solution dissolving 1 gram (g) of agarose in 50 mL of 0.9% NaCl (Cat. No. 
7647-14-15; mikroCHEM, Pezinok, Eslovakia) and autoclave it. The micro-molds for casting 
3D Petri Dishes® were also autoclaved before use. On an experimental day, agarose solution 
was boiled in the microwave to dissolve the agarose powder completely. Then, the molten 
agarose was placed in a 50 mL centrifuge tube in a thermoblock set up at 70ºC inside the 
laminar hood to maintain the aseptic conditions.  
 
Next, in a biosafety cabinet using the aseptic technique, 330 µL of molten agarose were 
pipetted into a 24-series micromold. After the agarose has gelled, the micromold was carefully 
flexed to remove the 3D Petri Dish®. Then, each 3D Petri Dish® (a micromolded agarose gel) 
was transferred to a well in a 24-well tissue culture plate (TTP) and organised aligned in the 
same position. Finally, to immobilize micromolded gels,130 μL of molten agarose (45°C) were 




To equilibrate 3D Petri Dish®, 1.0 mL of the culture medium was added to each well containing 
the agarose gel and incubated it overnight in an incubator.  
 
• Cell Seeding the 3D Petri Dish® 
 
The next day, cell splitting and seeding into each micromolded gel were carried out. The cell 
specification (the number of passages in monolayer cell culture, the number of cells per 
spheroids and per plate, and the volume needed) is in Table 1. The cell culture MEM medium 
was carefully removed from the outside of the 3D Petri Dish® and its inner chamber, trying not 
to damage the agarose gel. The cell suspension (65 µl with 4,000 cells per spheroids, i.e. 
140,000 cells in total per each 3D Petri Dish®) was added, dropwise, into the cell seeding 
chamber.   
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Table 1. Resume information about cell concentration and volume needed for cell seeding 
calculations.  
 
Nº Plate Plate A Plate B Plate C 
2D HepG2 Cell 
passage 
p13/p9 p13/p9 p2/p15 
Cells per 
spheroid 
4.000 cells per 
spheroids 
4.000 cells per 
spheroids 






3, 36 × 106 3, 36 × 106 3, 36 × 106 
Volume per 
well 
65 µl 65 µl 65 µl 
Final Volume 
per plate 
1560 µl 1560 µl 1560 µl 
 
 
After the seeding into the 3D Petri Dish® agarose gel, the cells were allowed (~10 min) to 
settle into the features (recesses) of the 3D Petri Dish®. Finally, 1.0 mL of the additional MEM 
medium was added to the outside of the agarose gel. Then, 24 well-plate was placed into the 
incubator and the culture medium was exchanged as needed. 
 
 
3D HepG2 Cell-based Transformation Assay 
 
Figure 5 shows a schema of the 3D HepG2 cell-based transformation assay. The spheroids 
were exposed as compact mature spheroids on the fourth day in the culture. The culture or 
exposure (the culture medium with the solvent or chemical) media were changed on the 4th, 






It is important to emphasize that there were five different exposure (treatment) conditions within 
a 28-day protocol: 
 
- Untreated spheroids (negative control, NC). The spheroids were incubated with the 
culture medium for the whole incubation/exposure time (28 days). The NC was in 
tetraplicate (35 spheroids per well × 4 wells = 140 spheroids). 
 
- Solvent treated control spheroids (solvent control, SC). The spheroids were treated 
with dimethyl sulfoxide (DMSO, Cat. No. C6614; Sigma-Aldrich) at the final concentration 
of 1.55× (v/v) on the 4th day, then with ethanol (EtOH; Cat. No. 493511; Sigma-Aldrich) at 
the final concentration of 1.0× % (v/v) on the 7th, 8th, 10th, 14th, 17th, 21st and 24th day. The 
SC was in tetraplicate (35 spheroids per well  4 wells = 140 spheroids). 
 
- 3-MC alone treated spheroids (3-MC). The spheroids were exposed to 3-MC (98% purity, 
Cat. No. 213942; Sigma-Aldrich) at the final concentration of 2 mg/mL on the 4th day and 
the rest of the days just with the culture medium. The 3-MC variant was in tetraplicate (35 
spheroids per well  4 wells = 140 spheroids). 
 
- TPA alone treated spheroids (TPA). The spheroids were incubated with just the culture 
medium for the first six days, then exposed to TPA (≥98% purity, Cat. No. 16561-29-8; 
Sigma-Aldrich) on the 7th, 8th, 10th, 14th, 17th, 21st, and 24th day. The TPA variant was in 
tetraplicate (35 spheroids per well × 4 wells = 140 spheroids). 
 
- 3-MC and TPA treated spheroids (3-MC + TPA). The spheroids were exposed to 3-MC 
at the final concentration of 2 g/mL on the 4th day, then exposed to TPA at the final 
concentration of 0.1 g/mL on the 7th, 8th, 10th, 14th, 17th, 21st, and 24th.The 3-MC+TPA 
















Figure 5. The schema of 3D HepG2 cell-based transformation assay. NC: negative control; 
SC: solvent control. 4D: four days interval; 3D: three days interval where 3-MC exposure 
occurs, starting the initiation phase of carcinogenic process; 21D: twenty one days interval 
where TPA exposure occurs, starting the promotion phase. Each vertical bar represents days 





Brightfield spheroid images were taken on the 1st, 4th, 7th, 8th, 10th, 14th, 17th, 21st, and 24th day. 
Images were acquired using the automated imaging system TissueFAXS equipped with a 
CMOS Baumer XG40c, using 2.5× objective as reported previously (16). The spheroids in the 
first well were manually focussed. Then, different parameters were adjusted, such as 
saturation, gamma, exposure time, white balance. The focus was either confirmed or re-
adjusted by the user for the subsequent wells throughout the acquisition. After that, the entire 
microplate was scanned in the preview mode first, then the region of interest (ROS) covering 
the whole spheroid array was defined for each hydrogel/microplate well and saved. Thanks to 
the adhesion of the agarose gels to the surface of the plate in a specific position, the template 
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with defined regions can be saved and used for repeated image acquisitions from the same 
plate. Once the photos were acquired, they were saved, stitched and exported with a region 




Image analysis was carried out using Fiji, an image processing package based on ImageJ 
(37,38). The Fiji/ImageJ programming language Jython was used to create a macro called the 
‘Spheroid.Macro.ijm’, which is designed to automatically detect spheroids in microphotographs 
in .jpg, .tiff and or .png format (16). It allows the evaluation of multiple spheroids per single 
image, including composite images of multiple fields of view.  
 
Firstly, in Analyze option in the toolbar, the following measurements were set: area, minimum 
and maximum gray values, center of mass, bounding rectangle, shape descriptors, integrate 
density, skewness, area fraction, centroid, perimeter, flit ellipse, Feret´s diameter, median. 
Nextly, in Plugin’s option, installed the ´Spheroid.Macro.ijm ´ and opened all the images 
through the SpheroidMacro. The scale was set up at 2.143 mm/pixel, size between 18000-
infinity and circularity was change depending on the image, being a number closer to zero less 
circular, and closer to one more circular. After that, the output result file showed the expected 
number of spheroids per image, and for each spheroid identified, the macro provided two main 
types of measurements: 
 
- Size measurements (Table 2) represented: area (μm2), the diameter of the fitted 
ellipse (major and minor axis, μm), Feret’s maximum and minimum diameter (μm), 
Feret´s diameter (μm), perimeter (μm) and volume.  
 
- Shape (Table 3) measurements represented: circularity (sphericity), aspect ratio, 
roundness, and solidity. 
 
- All the measurements obtained from each picture will be sump up in an excel file for 






Table 2. Measured size parameters of spheroids (39,40,41). 
 
Size Parameters 
 Unit Characteristics Formula 
Feret´s 
Diameter 
mm The longest distance between any 
two points along the selection 
boundary 
 
Volume mm3 The amount of space occupied by 
a three-dimensional object 
 
Perimeter mm The length of the outside boundary 
of the selection 
 
Area mm2 Expresses the extent of a 2D region, 
shape, or planar lamina, in the plan. 
Calculated in ImageJ as the sum of 




Table 3.  Measured shape parameters of spheroids (39,40).   
 
Shape Parameters 
 Unit Characteristics Formula 
Solidity Dimensionless Measurement of the overall 
concavity of a particle 
 
Roundness Dimensionless Specifies the deviation from the 
circular shape. As particle 
becomes circular, value 
approaches one. 
 
Circularity Dimensionless Specifies ideally circular object. A 
value of 1.0 indicating a perfect 
circle. As the value approaches 












To harvest spheroids, a new 24 wells plate was filled with PBS: 500mL per well. The gels with 
spheroids were transferred to this new plate with PBS solution. The gels were turned upside 
down and centrifuged for 3 min at 200 × g (5810 R Eppendorf, Říčany u Prahy, Czech 
Republic). Next, the spheroids for each variant (NC, SC, 3-MC, TPA, 3-MC+TPA) in PBS were 
transfer from a well to an Eppendorf. Eppendorf tubes were centrifuged, the supernatant was 
discarded, and spheroids were washed one more time with PBS. Finally, 500 mL of trizol (Cat. 
No. 15596018; Invitrogen, Waltham, MA, USA) were added, and the samples were stored in 
a freezer at -80C. Later on, RNA was isolated from these samples and reverse transcripted to 
cDNA. Then, the expression of genes associates with neoplastic and hepatocellular carcinoma 
cell lines phenotypes will be evaluated using RT-qPCR. 
 
Statistical Analysis  
 
Data expressed represented three independent experiments and presented as an average of 
these three experiments with standard deviation. Data related to the parameters with 
dimension (area, volume, perimeter, Feret´s diameter) were normalized to untreated controls 
for each exposure time and expressed as a percentage of untreated spheroids. Graphs were 
plotted using Graphpad Prism 4 (Graphpad software). Statistical analysis was carried out 
using one-way ANOVA with Dunnett´s post hoc test or two-tailed Student´s t-test after 













Spheroid Formation and Structure 
 
Spheroids of liver HepG2 cells were prepared using the 3D Petri Dish® micro-mold casting. 
The seeding density was 4,000 cells per spheroid. The spheroid formation and maturation 
were monitored by microscopic evaluation on the day 1, 4, 7, 8, 10, 14, 17, 21, 24 and 28 of 
spheroid culture. The parameters describing the spheroid size (area, volume, perimeter, 
Feret's diameter) and shape (circularity, roundness, aspect ratio, solidity) were analysed. The 
representative images of non-treated HepG2 spheroids are shown in Figure 6. After the first 
24 hours, spheroids have already been formed, with the area around 155,132 mm2, the volume 
around 2.98×107 mm3, the perimeter 1339 mm, and the Feret's diameter around 434 mm 
(Figure 7). Their shape was irregular with low circularity (around 0.74) and roundness (around 
0.917) and high AR (around 1.09) (Figure 8).  
 
The 1-day spheroids were not compact with solidity around 0.96. However, during the next 
three days (Day 1 to Day 4), the size of spheroids (area, perimeter and Feret's diameter) 
significantly decreased (Figure 7: area: *p≤0.05; perimeter: **p ≤ 0.01; and Feret's diameter: 
***p ≤ 0.001; one-way ANOVA with Dunnett's post hoc test), reaching the minimum value for 
these parameters among all the days. Additionally, their shape and compactness improved 
with circularity and solidity significantly higher (Figure 8: **p ≤ 0.01; ***p ≤ 0.001; one-way 
ANOVA with Dunnett's post hoc test). Thus, the compact, circular and round spheroids were 
formed on day 4. Between days 4 and 28, the HepG2 spheroids slowly grew and kept their 




Figure 6. The representative images of 3D HepG2 spheroids monitored by automatic 
microscopic platform TissueFAXS showing their formation and maturation within the culture. 
HepG2 cells were seeded into 2% agarose gels at a density of 4000 cells per spheroid. Scale 
































































































Figure 7. The size of the untreated spheroids (NC) and the spheroids treated with solvent (SC) 
within time. Each size parameter (A. area, B. volume, C. perimeter and D. Feret's diameter) is 
expressed as average from three independent experiments with standard deviation (n=3). The 
asterisk represents statistical significance from the spheroids on day 1 (*P≤0.05, **P ≤ 0.01, 
***P ≤ 0.001; one-way ANOVA with Dunnett's post hoc test). There was no statistical difference 
between parameter values for NS and SC for any exposure time (p > 0.05, two-tailed Student´s 
t-test). The red arrow in the graphs indicates the size of 1-day spheroids (24 hours after cell 




















































































Figure 8. The shape of untreated spheroids (NC) and the spheroids treated with solvent (SC) 
within time. Each shape parameter (A. circularity, B. roundness, C. aspect ratio, D. solidity) is 
expressed as average from three independent experiments with standard deviation (n=3). The 
asterisk represents statistical significance from the spheroids on day 1 (*P≤0.05, **P ≤ 0.01, 
***P ≤ 0.001; one-way ANOVA with Dunnett's post hoc test). There was no statistical difference 
between parameter values for NS and SC for any exposure time (p > 0.05, two-tailed Student´s 
t-test). The red arrow in the graphs indicates the size of 1-day spheroids (24 hours after cell 










3D HepG2 transformation assay 
 
The spheroids were exposed on day 4 when the spheroids were already compact and regular 
(Figure 6-8) after self-assembling and self-compacting. The exposure schema is in Figure 5. 
Firstly, it was essential to demonstrate that DMSO and EtOH used as solvent control do not 
affect spheroid size or shape. Therefore, we compared the SC with untreated control NC for 
each parameter and exposure time (Figure 7 and 8), and no statistical significance was 
confirmed (two-tailed Student´s t-test).  Thus, the solvent-treated spheroids mimicked the 
behaviour of non-treated spheroids within the culture concerning their size and shape (Figure 
9 and 10). The HepG2 spheroids were exposed to 3-MC alone (2 mg-mL) for the first three 
days (Day 4-Day 7), TPA alone for 21 days (Day 7-Day 28) and 3-MC+TPA, where the 
spheroids were exposed to 3-MC (Day 4-Day 7) followed by TPA exposure for 21 days (Day 
7-Day 28).  The morphology of spheroids treated with solvent, 3-MC alone, TPA alone and 3-
MC+TPA is shown in Figure 9 for the illustration.   
 
3-MC alone significantly reduced the spheroid size (Figure 10) and disturbed their shape and 
compactness (Figure 11). All parameters representing size gradually decreased within time, 
reaching their minimum around day 14, with the area around 54% of non-trated spheroids, 
volume 40%, perimeter 77%, and Feret's diameter around 108% (perimeter, Feret's diameter 
**p ≤ 0.01; area, volume: ***p ≤ 0.01; two-tailed t-test). Their shape was irregular with low 
circularity (minimum around 0.73%; circularity, *p ≤ 0.05) and solidity (minimum around 0.94%; 
***p ≤ 0.01) than for solvent control on the last days (Day 14 to 28) (Figure 11) compared to 
SC spheroids. Both parameters were decreasing within the entire exposure. As a result, the 
border of spheroids became irregular and less compact, and cell debris appeared around 
spheroids (Figure 9).  
 
TPA alone significantly increased spheroid perimeter (Figure 10) and reduced circularity and 
solidity (Figure 11). The perimeter is significantly bigger from day 8 until the end of the 
exposure (maximum 108%; *p ≤ 0.05; two-tailed t-test). Futhermore, TPA caused the irregular 
shape of spheroids with lower circularity (minimum around 0.73%; **p ≤ 0.01; two-tailed t-test) 





The size and shape of 3-MC + TPA-treated spheroids were similar to 3-MC treated 
spheroids.They were significantly reduced in the spheroid size (Figure 10) and shape (Figure 
11). All parameters representing size (area, volume, perimeter, Feret's diameter) and 
circularity and solidity parameters, gradually decreased within time. Size measures reached 
their minimum around day 14 (perimeter: *p ≤ 0.05; Feret's diameter **p ≤ 0.01; area, volume: 
***p ≤ 0.05) and keeping it by the end of the exposure, in contrast to circularity and solidity 
their minimun was reached around day 24. In addition, as 3-MC alone, 3-MC+TPA caused the 
irregular shape of spheroids with lower circularity and solidity (compactness) than SC. Both 
parameters were decreasing within the entire exposure (circularity minimum around 0,72, *p ≤ 
0.05; solidity minimun 0,944 ***p ≤ 0.01; two-tailed t-test). As a result, the border of spheroids 
became irregular and less compact, and cell debris appeared around spheroids (Figure 9).    
Figure 9.  Effect of 3-MC alone, TPA alone and 3-MC+TPA treatment on HepG2 spheroid 
morphology. The representative images are shown. The spheroid morphology was monitored 
by the automatic microscopic platform TissueFAXS. HepG2 cells were seeded into 2% 
agarose gels at a density of 4000 cells per spheroid. Scale bars represent 500 µm. 
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Figure 10. Effect of 3-MC alone, TPA alone and 3-MC+TPA treatment on HepG2 spheroid 
size. Each parameter (A. area, B. volume, C. perimeter and D. Feret's diameter) is expressed 
as average from three independent experiments with standard deviation (n=3) represented by 
the average values obtained from three independent experiments (n=3). The asterisk 
represents statistical significance from a corresponding solvent control (*P≤0.05, **P≤0.01, 
***P≤0.001; two-tailed t-test). The red arrow in the graphs indicates the size of 1-day spheroids 
(24 hours after cell seeding), the black arrow indicates when the chemical exposure started (4 
days after cell seeding). NC, non-treated spheroids (negative control); SC, solvent-treated 




































































































Figure 11. Effect of 3-MC alone, TPA alone and 3-MC+TPA treatment on HepG2 spheroid 
shape. Each parameter (A. area, B. volume, C. perimeter and D. Feret's diameter) is 
expressed as average from three independent experiments with standard deviation (n=3). The 
asterisk represents statistical significance from a corresponding solvent control (*P≤0.05, 
**P≤0.01, ***P≤0.001; two-tailed t-test). The red arrow in the graphs indicates the size of 1-day 
spheroids (24 hours after cell seeding), the black arrow indicates when the chemical exposure 
started (4 days after cell seeding). NC, non-treated spheroids (negative control); SC, solvent-









Discussion and Conclusions 
 
3D cell culture models are an attractive alternative to the 2D cell culture in vitro model. Thus, 
continuous development in the 3D mammalian cell culture systems improves cell-cell and cell-
ECM interactions and specific functionality, availability, reproducibility, scalability, and 
affordability (9,12). Among the 3D cell models, scaffold-free 3D spheroid cultures represent a 
suitable in vitro model for screening purposes, and it is increasingly used as a new 3D culture 
technique. The spheroids mimic a close physiological microenvironment characteristic of 
physiological tissues or tumors, maintaining normal cell characteristics related to cell-cell, and 
cell-ECM contacts (12).  
 
Carcinogenesis is recognized as a multipath process in which distinct molecular and cellular 
alterations occur, consisting of separate but closely linked stages of initiation, where 
mutations or gene alteration arise promotion, where preneoplastic cells proliferate and 
accumulate, and progression, the final stage of neoplastic transformation (5,10). Therefore, 
different transformation assays could be performed with exogenous initiating (3-MC, DMBA) 
and promoting (TPA) chemical carcinogens to induce carcinogenesis process.  
 
Traditionally, animals are required to assess the carcinogenic potential of chemicals despite  
their ethical, practical, and economic limitations (13). In addition, with the implementation of 
the 3R principles, new efficient in vitro cell models are in continuous development and should 
refine animal-based testing even for carcinogenicity assessment and research. Traditional 2D 
CTAs use 2D models of different cell lines, namely SHE, BALB/c 3T or Bhas 42 cells 
(14,19,42). The 2D models generally are characterized by the growth of the cells in a flat 
monolayer, attached to the stiff surface. The main disadvantage of 2D models is the lack of 
biological functions due to limited cell-to-cell and cell-to matrix interactions, resulting in loss of 
cell differentiation, modification in signalling pathways and depletion of the expression of 
important enzymes, which can consequence in misleading results (16,20).  That is maybe why 
these CTAs, even after their validation, were not considered alternatives for assessing 
chemicals' carcinogenic potential yet (14) 
 
Newly alternative developed 3D cell culture models, including 3D liver models, present a better 
cell-cell interaction and similarity to in vivo situation. Specifically, 3D liver models have a higher 
levels of liver-specific functions, including metabolic enzyme activities as well as cell 
morphology and biochemical properties, which reflect in vivo conditions in the liver more 
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accurately (20). That is why it is important to establish a new hepatic in vitro model that mimics 
as much as possible the liver microenvironment, including the tumor carcinogenic cell 
environment.  
 
From our results, it is clear that, for a seeding density of 4000 HepG2 cells per spheroids 4 
days are necessary to self-assembly and self- compactness. The spheroids self-assembly and 
self-compactness affect to their area, perimeter, Feret's diameter, circularity and solidity during 
the first four days. On the other hand, the volume of the spheroids did not significantly change 
within time, suggesting that the spheroid volume do not change during the time of spheroids 
culture. The roundness and AR of spheroids also did not significantly change within time, 
suggesting that the roundness and AR of spheroids do not change during the time of spheroids 
culture. From day 4, steady growth of spheroids during the time of culture appeared without 
shape changes. The protocol for HepG2 spheroids has been optimized and was reproducible 
independently.  
 
In addition, we developed and optimized a new 3D HepG2 cell-based transformation assay. 
We adopted the protocols of 2D CTAs, where 3-MC was successfully applied as an initiator 
and TPA as a tumor promotor. We used their effective concentrations and exposure times for 
these 2D models. We monitored spheroid size and shape within the entire exposure. After self-
assembly, the compact and mature spheroids were exposed. The spheroids treated with 
DMSO or ethanol as solvent control did not differ from the non-treated spheroids in area, 
volume, perimeter Feret's diameter size and shape parameters. The spheroids treated with 3-
MC and TPA or 3-MC alone were characterized by smaller size and irregular shape, especially 
low circularity and irregular spheroid border, and lower compactness (solidity). In contrast, 
roundness and AR values were not significantly altered. Similarly, the spheroids treated with 
TPA alone had similar roundness and AR as the control ones. On the other hand, their 
perimeter, area, volume and Feret's diameter were higher and circularity and solidity lower. 
The changes induced by 3-MC, TPA and 3-MC+TPA suggest that these exposure variants can 
lead to alternations related to their carcinogenicity potential (13,19).  
 
However, to confirm cell transformation in the exposed spheroids, it is necessary to evaluate 
the expression of genes associates with neoplastic and hepatocellular carcinoma cell lines 
phenotypes using RT-qPCR. Therefore, we will focus on the genes involved in 1) the regulation 
of cell proliferation, regeneration and apoptosis (PCNA, Cyclin D1, p-S6, Ki67, Bcl-2); 2) drug 
resistance (MDR1, MRP2, BCRP) and 3) adhesion and epithelium mesenchymal transition 
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(MMP-2/9 or E-cadherin/N-cadherin) (43). In parallel, the functionality of spheroids will be 
assessed by measuring albumin, urea or lactate in the collected medium (18,43). 
 
In conclusion, the 3D CTA assay utilizing 3D spheroid models of HepG2 cells can be a 
promising tool for screening carcinogenicity potential of chemicals or new anti-cancer in 
biomedical, pharmacological and toxicological research and their applications. However, this 
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